Monday, June 14, 2021

Ayush Ministry says, scientists have found AYUSH 64 useful in treatment of asymptomatic, mild and moderate COVID-19 infection

Ayush Ministry has said that scientists have found that AYUSH 64 is useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care. AYUSH 64 is a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences. Initially the drug was developed for Malaria in the year 1980 and now is repurposed for COVID-19. Ayush Ministry and Council of Scientific and Industrial Research in collaboration have completed a robust multi-centre clinical trial to evaluate it’s safety and efficacy.

Director, Centre for Rheumatic Diseases, Pune and honorary chief clinical coordinator of the Ministry of Ayush – CSIR collaboration, Dr Arvind Chopra stated that AYUSH 64 as an adjunct to standard of care showed significant improvement and thus lesser period of hospitalization as compared to standard of care alone. He also said that significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general happiness and sleep were also observed. He also added that patients on AYUSH 64 will still require monitoring so as to identify any worsening of disease.

National Research Professor, Ayush and Chairman of the Inter-disciplinary Ayush Research and Development Task Force on COVID-19, Dr. Bhushan Patwardhan said that the results of AYUSH 64 study are highly encouraging where a reasonably good scientific evidence has emerged. He said that this is a time tested, safe and effective ayurvedic medicine. He informed that the results of the clinical trials would soon be published in reputed scientific journals. The Ayush Ministry has said that in the current situation, this positive finding by scientists of reputed research institutions brings a ray of hope.

- Advertisement -
Latest news

Sensex rises 76 points, Nifty ends at 15,811; IT and Banking stocks in the lead

Equity benchmark indices Sensex and Nifty50 ended on the green side of the market on Friday. Buying interest was seen in PSU bank and...

Centre allocates 1,06,300 vials of anti fungal drug Liposomal Amphotericin B across all States, UTs and Central Institutions

Union Minister for Chemicals and Fertilizers D.V. Sadananda Gowda has informed that 1,06,300 vials of anti fungal drug Liposomal Amphotericin B have been allocated...

NCPCR asks social media platforms to share information about social media posts for direct adoption of children orphaned during COVID-19 pandemic

National Commission for Protection of Child Rights (NCPCR) has asked social media platforms to share information about the social media posts being published for...

AIIMS, Delhi to start recruitment for COVID vaccine clinical trials for children in 6 to 12 yrs age group Tuesday onwards

The All India Institute of Medical Sciences in Delhi will start recruitment for clinical trials tomorrow onwards for the children who are in the...
Related news

Sensex rises 76 points, Nifty ends at 15,811; IT and Banking stocks in the lead

Equity benchmark indices Sensex and Nifty50 ended on the green side of the market on Friday. Buying interest was seen in PSU bank and...

Centre allocates 1,06,300 vials of anti fungal drug Liposomal Amphotericin B across all States, UTs and Central Institutions

Union Minister for Chemicals and Fertilizers D.V. Sadananda Gowda has informed that 1,06,300 vials of anti fungal drug Liposomal Amphotericin B have been allocated...

NCPCR asks social media platforms to share information about social media posts for direct adoption of children orphaned during COVID-19 pandemic

National Commission for Protection of Child Rights (NCPCR) has asked social media platforms to share information about the social media posts being published for...

AIIMS, Delhi to start recruitment for COVID vaccine clinical trials for children in 6 to 12 yrs age group Tuesday onwards

The All India Institute of Medical Sciences in Delhi will start recruitment for clinical trials tomorrow onwards for the children who are in the...